Skip to Content
Merck
  • MLKL, a new actor of UVB-induced apoptosis in human diploid dermal fibroblasts.

MLKL, a new actor of UVB-induced apoptosis in human diploid dermal fibroblasts.

Cell death discovery (2024-05-15)
Anne-Sophie Gary, Sophie Amouret, Alicia Montoni, Patrick J Rochette
ABSTRACT

Ultraviolet radiation (UVR) is a major environmental mutagen. In skin, UVR can initiate cancer through the induction of mutagenic DNA damage and promote its progression. An important cancer prevention mechanism is the regulated cell death (RCD), which can safely dispose of damaged cells. Apoptosis, a well-known RCD, is known to be activated by UVR, but part of the mechanism and proteins involved in UVR-induced apoptosis are still to be discovered. Receptor-interacting serine/threonine-protein kinase 3 (RIPK3) and mixed lineage kinase domain-like (MLKL) are two proteins involved in necroptosis, a form of RCD. Here, we have evaluated the implication of RIPK3 and MLKL in UVB-induced cell death in human diploid dermal fibroblasts. Our results show that RIPK3 and MLKL play opposite roles in UVB-induced cell death, in a necroptosis independent pathway. We showed that RIPK3 protects cells from UVB cell death, while MLKL sensitizes cells to UVB-induced apoptosis. Taken together these results are the first to show the implication of RIPK3 and MLKL in survival and apoptosis, respectively, bringing two new actors in UVB-induced cell death pathway.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-MLKL Antibody, clone 3H1, clone 3H1, from rat
Sigma-Aldrich
Anti-RIP3 Antibody, clone 6E6.2, clone 6E6.2, from mouse